Boyer & Corporon Wealth Management, LLC Amgen Inc Transaction History

Boyer & Corporon Wealth Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $340,681 - $389,878	-1,713 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $5,193 - $6,184	-24 Reduced 1.38%	1,713 $394,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $1,275 - $1,691	-7 Reduced 0.4%	1,737 $352,000
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $5,487 - $7,052	-29 Reduced 1.64%	1,744 $420,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $18,629 - $22,322	-107 Reduced 5.69%	1,773 $343,000
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $20,170 - $23,644	-121 Reduced 6.05%	1,880 $346,000
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $1,446 - $1,631	-8 Reduced 0.4%	2,001 $380,000
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $3,211 - $3,748	-18 Reduced 0.89%	2,009 $3.91 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $996 - $1,119	-6 Reduced 0.3%	2,027 $374,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $5,082 - $5,940	-30 Reduced 1.45%	2,033 $347,000
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $1,181 - $1,320	-7 Reduced 0.34%	2,063 $359,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $346,290 - $395,370	2,070	2,070 $386,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Boyer & Corporon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boyer & Corporon Wealth Management, LLC with notifications on news.